Carbone Pp
- Oncology top 10%
- Cancer Treatment and Pharmacology 8
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
-
- Lung Cancer Treatments and Mutations 6
-
- Multiple Myeloma Research and Treatments 2
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 2
-
- Fungal Plant Pathogen Control 1
-
- Click Chemistry and Applications 1
- Co-authors
- Owens AhJ EdmonsonMarvin A. SchneidermanBruce I. ShniderJoseph ScottoHolland JfCharles L. SpurrMoertel Cg
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (3 papers)PubMed (25 papers)
- Partner nations
- United States
In The Last Decade
Carbone Pp
28 papers receiving 440 citations
Peers
Comparison fields: 5 of 72
- Oncology 270
- Pathology and Forensic Medicine 137
- Genetics 67
- Pulmonary and Respiratory Medicine 170
- Hematology 53
Countries citing papers authored by Carbone Pp
This map shows the geographic impact of Carbone Pp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carbone Pp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carbone Pp more than expected).
Fields of papers citing papers by Carbone Pp
This network shows the impact of papers produced by Carbone Pp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carbone Pp. The network helps show where Carbone Pp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carbone Pp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma. | 1984 | 5 |
| 2 | Aspergillosis infection following radiotherapy. | 1984 | 3 |
| 3 | Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275). | 1979 | 7 |
| 4 | Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". | 1979 | 28 |
| 5 | Phase II study of adriamycin and bleomycin in patients with multiple myeloma. | 1978 | 13 |
| 6 | Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancer. | 1977 | 11 |
| 7 | Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report. | 1977 | 24 |
| 8 | Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group. | 1976 | 6 |
| 9 | Eastern Cooperative Oncology Group studies with DTIC (NSC-45388). | 1976 | 27 |
| 10 | Adriamycin in the treatment of far-advanced lung cancer. | 1976 | 15 |
| 11 | Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma. | 1976 | 6 |
| 12 | Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly. | 1975 | 7 |
| 13 | Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. | 1968 | 108 |
| 14 | Immunosuppression with lymph depletion in man. | 1967 | 5 |
| 15 | Treatment of Hodgkin's disease. | 1967 | 5 |
| 16 | Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. | 1966 | 1 |
| 17 | Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity. | 1966 | 13 |
| 18 | Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. | 1965 | 181 |
| 19 | 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. | 1964 | 5 |
| 20 | Clinical trial of vinblastine in multiple myeloma. | 1963 | 8 |
About Carbone Pp
Carbone Pp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hematology and Pathology and Forensic Medicine, having authored 28 papers that have together received 548 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers), Fungal Plant Pathogen Control (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (270 citations), Pathology and Forensic Medicine (137 citations), Genetics (67 citations), Pulmonary and Respiratory Medicine (170 citations) and Hematology (53 citations). Carbone Pp has collaborated with scholars based in United States. Frequent co-authors include Owens Ah, J Edmonson, Marvin A. Schneiderman, Bruce I. Shnider, Joseph Scotto, Holland Jf, Charles L. Spurr, Moertel Cg, Jacob Colsky and P F Engstrom. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.